Skip to main content
Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025

Revenue by Product

Fiscal year is March - February.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Feb '23 Feb '22 Feb '21 Feb '20 Feb '19
Contract Development
486.60K
Log In
Log In
Log In
Log In
Contract Development Growth
300.20%
Log In
Log In
Log In
Log In
White Label
456.96K
Log In
Log In
Log In
Log In
White Label Growth
1.46%
Log In
Log In
Log In
Log In
Nutraceuticals
31.49K
Log In
Log In
Log In
Log In
Nutraceuticals Growth
-40.89%
Log In
Log In
Log In
Log In
Research Program
25.10K
Log In
Log In
Log In
Log In
Product Testing
13.80K
Log In
Log In
Log In
Log In
Product Testing Growth
-0.94%
Log In
Log In
Log In
Log In
Other Non-cannabis Product
6.47K
Log In
Log In
Log In
Log In
Other Non-cannabis Product Growth
-91.82%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is March - February.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Feb '23 Feb '22 Feb '21 Feb '20 Feb '19
Canada
1.02M
Log In
Log In
Log In
Log In
Canada Growth
42.06%
Log In
Log In
Log In
Log In